Dr. Ali Hmaidat, a researcher from the Department of Pharmaceutics and Pharmaceutical Technology at the Faculty of Pharmacy, Yarmouk University, has successfully published a distinguished scientific study in Signal Transduction and Targeted Therapy, a prestigious international scientific journal specializing in cellular signaling and targeted therapy research and published under the Nature portfolio.

This scientific achievement comes within the framework of international research partnerships and academic networking associated with summer research visit programs. Publishing this work in a journal with a very high impact factor exceeding 50, according to the latest 2024 data, is a strong indicator of the quality of the research and its scientific significance in the fields of cancer and immunology.

The study explores new mechanisms to enhance the effectiveness of immunotherapy in ovarian cancer by inhibiting RNA-binding proteins, paving the way for innovative therapeutic strategies based on targeting molecular pathways.

This publication represents a notable addition to the university’s research journey and its support for scientific research. It also reflects the Faculty of Pharmacy’s commitment to promoting scientific excellence, strengthening international collaboration, and providing advanced opportunities for young researchers to contribute to the production of high-impact knowledge.

The journal link is provided below: